Huashan Liu

1.1k total citations · 3 hit papers
13 papers, 715 citations indexed

About

Huashan Liu is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Huashan Liu has authored 13 papers receiving a total of 715 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Immunology and 5 papers in Oncology. Recurrent topics in Huashan Liu's work include Cancer Immunotherapy and Biomarkers (4 papers), Epigenetics and DNA Methylation (3 papers) and Extracellular vesicles in disease (2 papers). Huashan Liu is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), Epigenetics and DNA Methylation (3 papers) and Extracellular vesicles in disease (2 papers). Huashan Liu collaborates with scholars based in China. Huashan Liu's co-authors include Zhenxing Liang, Ping Lan, Xiaobin Zheng, Xianrui Wu, Tuo Hu, Xiaowen He, Chi Zhou, Chi Zhou, Fengwei Wang and Jianhong Peng and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and British Journal of Cancer.

In The Last Decade

Huashan Liu

12 papers receiving 712 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor-derived lactate promotes resistance to bevacizumab treatment by facilitating autophagy enhancer protein RUBCNL expression through histone H3 lysine 18 lactylation (H3K18la) in colorectal cancer

2023 240 citations Weihao Li, Chi Zhou et al. Autophagy profile →
Exosome circATP8A1 induces macrophage M2 polarization by regulating the miR-1-3p/STAT6 axis to promote gastric cancer progression

2024 82 citations Mingyu Huo, Xiaomei Zhuang et al. Molecular Cancer profile →
Mutant KRAS-activated circATXN7 fosters tumor immunoescape by sensitizing tumor-specific T cells to activation-induced cell death

2024 62 citations Wenxin Li, Xianrui Wu et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Huashan Liu China	7	458	292	180	137	59	13	715
Wenchang Lv China	16	546 1.2×	353 1.2×	113 0.6×	139 1.0×	74 1.3×	34	869
Manoj M. Pillai United States	18	557 1.2×	236 0.8×	141 0.8×	231 1.7×	133 2.3×	39	897
Na Luo China	13	373 0.8×	180 0.6×	126 0.7×	115 0.8×	96 1.6×	22	715
Monia Billi Italy	15	561 1.2×	355 1.2×	102 0.6×	126 0.9×	73 1.2×	17	922
Jianfeng Sang China	12	459 1.0×	368 1.3×	97 0.5×	130 0.9×	32 0.5×	42	692
Carla Riera‐Domingo Belgium	5	263 0.6×	257 0.9×	325 1.8×	146 1.1×	68 1.2×	6	662
Linda Pestano United States	14	694 1.5×	483 1.7×	97 0.5×	71 0.5×	52 0.9×	25	990
Ida Katrine Lund Denmark	18	335 0.7×	356 1.2×	132 0.7×	264 1.9×	44 0.7×	43	839
Chunhui Zhou China	10	294 0.6×	176 0.6×	121 0.7×	158 1.2×	31 0.5×	29	564

Countries citing papers authored by Huashan Liu

Since Specialization

Citations

This map shows the geographic impact of Huashan Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huashan Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huashan Liu more than expected).

Fields of papers citing papers by Huashan Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huashan Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huashan Liu. The network helps show where Huashan Liu may publish in the future.

Co-authorship network of co-authors of Huashan Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Huashan Liu. A scholar is included among the top collaborators of Huashan Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huashan Liu. Huashan Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Xiong, Li, Huashan Liu, Xianrui Wu, et al.. (2025). Glutamic-pyruvic transaminase 1 deficiency–mediated metabolic reprogramming facilitates colorectal adenoma-carcinoma progression. Science Translational Medicine. 17(779). eadp9805–eadp9805. 3 indexed citations

Liang, Zhenxing, Zhiping Chen, Yang Li, et al.. (2025). KDM4A-induced tumor senescence enhances the efficacy of immunotherapy by inhibiting AGT-PHB1 axis-mediated mitophagy in colorectal cancer. Autophagy. 21(12). 2982–3003.

Li, Wenxin, Xianrui Wu, Sijing Cheng, et al.. (2024). Mutant KRAS-activated circATXN7 fosters tumor immunoescape by sensitizing tumor-specific T cells to activation-induced cell death. Nature Communications. 15(1). 499–499. 62 indexed citations breakdown →

Kang, Liang, et al.. (2024). Three-year disease-free survival after transanal vs. laparoscopic total mesorectal excision for rectal cancer (TaLaR): A randomized clinical trial.. Journal of Clinical Oncology. 42(16_suppl). 3516–3516. 1 indexed citations

Huo, Mingyu, Xiaomei Zhuang, Wenchao Li, et al.. (2024). Exosome circATP8A1 induces macrophage M2 polarization by regulating the miR-1-3p/STAT6 axis to promote gastric cancer progression. Molecular Cancer. 23(1). 49–49. 82 indexed citations breakdown →

Liu, Huashan, Wenfeng Liang, Pinzhu Huang, et al.. (2024). Mitochondrial DNA copy number plays opposing roles in T-lymphocyte infiltration of colorectal cancer based on mismatch repair status: new directions for immunotherapy?. British Journal of Cancer. 130(5). 798–807. 3 indexed citations

Zeng, Ziwei, Yonghua Cai, Xin Yang, et al.. (2024). PHLDA1 protects intestinal barrier function via restricting intestinal epithelial cells apoptosis in inflammatory bowel disease. Experimental Cell Research. 443(1). 114322–114322. 1 indexed citations

Zeng, Ziwei, et al.. (2024). The relationship of KRAS expression with KRAS status, prognosis, and tumor-infiltrated T lymphocytes in colorectal cancer. Therapeutic Advances in Gastroenterology. 17. 1118432363–1118432363. 1 indexed citations

Li, Weihao, Chi Zhou, Long Yu, et al.. (2023). Tumor-derived lactate promotes resistance to bevacizumab treatment by facilitating autophagy enhancer protein RUBCNL expression through histone H3 lysine 18 lactylation (H3K18la) in colorectal cancer. Autophagy. 20(1). 114–130. 240 indexed citations breakdown →

10.

Liu, Huashan, Ziwei Zeng, Zhenxing Liang, et al.. (2023). KRT17 Promotes T-lymphocyte Infiltration Through the YTHDF2–CXCL10 Axis in Colorectal Cancer. Cancer Immunology Research. 11(7). 875–894. 52 indexed citations

11.

Liu, Huashan, Zhenxing Liang, Chi Zhou, et al.. (2021). Mutant KRAS triggers functional reprogramming of tumor-associated macrophages in colorectal cancer. Signal Transduction and Targeted Therapy. 6(1). 144–144. 61 indexed citations

12.

Liu, Huashan, Zhenxing Liang, Fengwei Wang, et al.. (2020). Intestinal CD14+ Macrophages Protect CD4+ T Cells From Activation-induced Cell Death via Exosomal Membrane TNF in Crohn’s Disease. Journal of Crohn s and Colitis. 14(11). 1619–1631. 22 indexed citations

13.

Liu, Huashan, Zhenxing Liang, Fengwei Wang, et al.. (2019). Exosomes from mesenchymal stromal cells reduce murine colonic inflammation via a macrophage-dependent mechanism. JCI Insight. 4(24). 187 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact